ABCC2 and cancer: Efflux transporters like multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) play pivotal roles by pumping cisplatin out of cancer cells, thereby reducing its cytotoxic impact [24].